Lifeon Pharmaceutical: The listing application for the chemical raw material Danpi Phenol has been approved
I'm LongbridgeAI, I can summarize articles.Lifeon Pharmaceutical announced that its application for the market launch of the chemical raw material Danpi Phenol has been approved by the National Medical Products Administration. As a component of traditional Chinese medicine, Danpi Phenol has a wide range of pharmacological effects and is mainly used to treat pain, tumors, and cardiovascular diseases. Its formulation, Danpi Phenol ointment, can be used for anti-allergy, anti-inflammatory, and itching relief, suitable for skin issues such as eczema and dermatitis. Currently, there is no import registration for Danpi Phenol raw materials in the domestic market, and only two companies have their domestic raw materials registered
According to the Zhitong Finance APP, Lifeon Pharmaceutical (003020.SZ) announced that it has recently received the "Approval Notice for the Application for Market Access of Chemical Raw Materials" for Danpi Phenol issued by the National Medical Products Administration.
As a monomer component of traditional Chinese medicine, Danpi Phenol has a wide range of pharmacological effects, particularly effective against various pains, tumors, and cardiovascular diseases. Its formulation, Danpi Phenol Ointment, is primarily used for anti-allergy, with anti-inflammatory and anti-itch effects, applicable to various skin conditions such as eczema, dermatitis, skin itching, and redness and swelling from insect bites. It also has certain effects on allergic rhinitis and the prevention and treatment of colds. As of the date of this announcement, there are no registered imports of Danpi Phenol raw materials. Besides the company, there are currently two domestic enterprises with registered raw materials, both with a registration status of "A" (approved for use in marketed formulations)